Estados financieros detallados de Coherus Oncology, Inc. (CHRS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Coherus Oncology, Inc. registró ingresos de $42.2M en el último ejercicio fiscal, con un CAGR de 5 años del -38.4%.
Márgenes de los últimos 12 meses: margen bruto 63.6%, margen operativo -307.4%, margen neto -257.1%.
Al precio actual de $1.22, CHRS presenta beneficios negativos (P/E no significativo) y un ROE del -181.73%. La capitalización bursátil es de $188M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $190.1M | $1.6M | $1.6M | $356.1M | $475.8M | $326.6M | $211.0M | $257.2M | $267.0M | $42.2M |
| Coste de Ventas | $254.4M | $160.5M | $3.2M | $17.1M | $37.7M | $57.6M | $70.1M | $159.0M | $117.6M | $17.7M |
| Beneficio Bruto | -$64.3M | -$159.0M | -$1.7M | $339.0M | $438.2M | $269.0M | $141.0M | $98.3M | $149.4M | $24.4M |
| I+D | $254.4M | $162.4M | $110.2M | $94.2M | $142.8M | $363.1M | $199.4M | $109.4M | $93.3M | $105.0M |
| Generales y Administrativos | $51.6M | $71.3M | $94.2M | $137.0M | $139.1M | $169.7M | $198.5M | $185.6M | $150.4M | $99.0M |
| Gastos Operativos | $306.0M | $233.7M | $204.4M | $231.2M | $281.8M | $532.8M | $397.8M | $301.5M | $261.1M | $204.0M |
| Beneficio Operativo | -$115.9M | -$232.1M | -$204.4M | $107.8M | $156.3M | -$263.9M | -$256.9M | -$203.2M | -$111.7M | -$179.5M |
| EBITDA | -$116.8M | -$225.3M | -$204.4M | $111.0M | $161.8M | -$260.7M | -$255.6M | -$193.9M | $60.9M | -$170.2M |
| Gastos por Intereses | $8.0M | $9.6M | $9.7M | $17.6M | $21.2M | $23.0M | $32.5M | $40.5M | $27.2M | $9.0M |
| Beneficio Antes de Impuestos | -$127.8M | -$238.3M | -$209.4M | $92.8M | $135.7M | -$287.1M | -$291.8M | -$238.3M | $28.5M | -$183.1M |
| Impuestos | $656000 | 0 | 0 | $2.9M | $3.5M | 0 | 0 | -$380000 | 0 | 0 |
| Beneficio Neto | -$127.3M | -$238.2M | -$209.3M | $89.8M | $132.2M | -$287.1M | -$291.8M | -$237.9M | $28.5M | -$170.3M |
| BPA | $-3.04 | $-4.48 | $-3.22 | $1.29 | $1.85 | $-3.81 | $-3.76 | $-2.53 | $0.25 | $-1.45 |
| BPA Diluido | $-3.04 | $-4.48 | $-3.22 | $1.23 | $1.62 | $-3.81 | $-3.76 | $-2.53 | $0.25 | $-1.45 |
| Acciones en Circulación (Diluidas) | $41.9M | $53.1M | $65.0M | $73.2M | $83.5M | $75.4M | $77.6M | $94.2M | $114.8M | $120.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $11.6M | $12.7M | $12.3M | $14.3M |
| Beneficio Bruto | $6.9M | $7.8M | $7.6M | $10.1M |
| Beneficio Operativo | -$42.2M | -$45.9M | -$36.2M | -$32.3M |
| EBITDA | -$41.2M | -$43.2M | -$33.9M | -$30.2M |
| Beneficio Neto | -$35.1M | -$37.3M | -$37.9M | -$20.6M |
| BPA | $-0.30 | $-0.31 | $-0.28 | $-0.13 |
| BPA Diluido | $-0.30 | $-0.31 | $-0.28 | $-0.13 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $124.9M | $126.9M | $72.4M | $177.7M | $541.2M | $417.2M | $63.5M | $102.9M | $126.0M | $88.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $128.1M | $14.9M | 0 | $83.2M |
| Cuentas por Cobrar | $1.9M | 0 | 0 | $142.0M | $157.0M | $123.0M | $110.0M | $260.5M | $122.3M | $18.4M |
| Inventario | -$4.8M | 0 | $1.7M | $9.8M | $44.2M | $37.6M | $38.8M | $62.6M | $70.1M | $3.2M |
| Activos Corrientes | $124.9M | $126.9M | $72.4M | $343.0M | $767.5M | $602.3M | $381.2M | $475.6M | $341.6M | $206.7M |
| Inmovilizado Material | $10.8M | $12.8M | $6.7M | $16.5M | $10.1M | $7.8M | $8.8M | $5.1M | $2.8M | $1.3M |
| Fondo de Comercio | $943000 | $943000 | $943000 | $943000 | $943000 | $943000 | $943000 | $943000 | 0 | 0 |
| Activos Intangibles | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $5.0M | $70.7M | $53.6M | $46.2M |
| Activos Totales | $178.5M | $162.6M | $99.5M | $408.9M | $841.6M | $679.3M | $480.8M | $629.6M | $448.5M | $258.3M |
| Cuentas por Pagar | $20.6M | $15.7M | $15.3M | $26.0M | $15.2M | $16.2M | $11.5M | $35.2M | $28.5M | $9.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $56.4M | $28.4M | $33.3M | $115.0M | $145.7M | $165.3M | $138.7M | $331.8M | $283.0M | $141.9M |
| Deuda a Largo | $100.3M | $101.6M | $103.1M | $178.4M | $404.0M | $408.3M | $471.1M | $473.4M | $264.9M | $37.1M |
| Pasivos Totales | $159.1M | $132.1M | $138.1M | $303.7M | $560.7M | $581.6M | $618.3M | $823.0M | $580.5M | $197.3M |
| Reservas | -$537.3M | -$775.5M | -$984.8M | -$895.0M | -$762.8M | -$1.05B | -$1.34B | -$1.58B | -$1.55B | -$1.38B |
| Patrimonio Neto | $19.4M | $30.5M | -$38.6M | $105.2M | $281.0M | $97.7M | -$137.4M | -$193.4M | -$132.0M | $61.0M |
| Deuda Total | $100.3M | $101.4M | $103.1M | $188.6M | $417.1M | $419.0M | $480.4M | $480.8M | $269.9M | $40.3M |
| Deuda Neta | -$24.7M | -$25.5M | $30.7M | $11.0M | -$124.1M | $1.8M | $288.7M | $363.1M | $143.9M | -$131.8M |
| Capital Circulante | $68.6M | $98.5M | $39.1M | $228.0M | $621.8M | $437.0M | $242.5M | $143.9M | $58.6M | $64.8M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $103.4M | $88.9M | $115.2M | $82.9M |
| Activos Totales | $516.5M | $258.3M | $266.0M | $191.2M |
| Pasivos Totales | $428.7M | $197.3M | $187.4M | $130.3M |
| Patrimonio Neto | $87.8M | $61.0M | $78.6M | $60.8M |
| Deuda Total | $40.7M | $40.3M | $54.4M | $37.7M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$127.8M | -$238.3M | -$209.4M | $89.8M | $132.2M | -$287.1M | -$291.8M | -$237.9M | $28.5M | $168.0M |
| Amortizaciones | $3.0M | $3.4M | $3.2M | $3.3M | $2.9M | $3.5M | $3.7M | $3.8M | $5.3M | $3.9M |
| Compensación en Acciones | $27.4M | $36.1M | $34.8M | $33.6M | $38.2M | $51.4M | $50.7M | $43.1M | $27.8M | $17.0M |
| Cambio en Capital Circulante | -$159.2M | -$5.1M | $10.3M | -$113.9M | -$34.7M | $42.4M | -$79.3M | -$36.8M | $55.9M | -$5.8M |
| Flujo de Caja Operativo | -$252.5M | -$200.3M | -$159.3M | $28.4M | $154.1M | -$37.4M | -$241.1M | -$174.9M | -$20.4M | -$138.5M |
| Inversiones (CapEx) | -$6.5M | -$4.6M | -$789000 | -$12.9M | -$7.2M | -$1.3M | -$2.0M | -$286000 | 0 | 0 |
| Adquisiciones | 0 | 0 | -$700000 | $1.7M | 0 | $1.3M | 0 | $845000 | 0 | 0 |
| Recompra de Acciones | 0 | -$544000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$259.1M | -$204.9M | -$160.1M | $15.5M | $146.9M | -$38.7M | -$243.2M | -$175.2M | -$20.4M | -$138.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$46.3M | -$19.7M | -$57.9M | -$120.0M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$46.3M | -$19.7M | -$57.9M | -$120.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $3.4M | $10.8M | $2.4M | $5.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -99.2% | +0.0% | +22783.7% | +33.6% | -31.4% | -35.4% | +21.9% | +3.8% | -84.2% |
| Crecimiento Beneficio Neto (anual) | | -87.0% | +12.1% | +142.9% | +47.2% | -317.1% | -1.6% | +18.5% | +112.0% | -697.4% |
| Crecimiento BPA (anual) | | -47.4% | +28.1% | +140.1% | +43.4% | -305.9% | +1.3% | +32.7% | +109.9% | -680.0% |
| Cambio en Acciones (anual) | | +26.8% | +22.4% | +12.5% | +14.1% | -9.6% | +2.9% | +21.3% | +21.9% | +4.8% |
| Crecimiento FCF (anual) | | +20.9% | +21.9% | +109.7% | +850.4% | -126.4% | -528.0% | +28.0% | +88.3% | -577.7% |
| Margen Bruto | -33.8% | -10216.9% | -107.9% | 95.2% | 92.1% | 82.4% | 66.8% | 38.2% | 56.0% | 57.9% |
| Margen Operativo | -61.0% | -14918.8% | -13137.3% | 30.3% | 32.9% | -80.8% | -121.7% | -79.0% | -41.8% | -425.7% |
| Margen EBITDA | -61.4% | -14481.7% | -13137.3% | 31.2% | 34.0% | -79.8% | -121.1% | -75.4% | 22.8% | -403.6% |
| Margen Neto | -67.0% | -15306.6% | -13453.7% | 25.2% | 27.8% | -87.9% | -138.2% | -92.5% | 10.7% | -403.8% |
| Margen FCF | -136.3% | -13165.7% | -10286.3% | 4.3% | 30.9% | -11.9% | -115.2% | -68.1% | -7.7% | -328.4% |
| Tasa Impositiva Efectiva | -0.5% | -0.0% | -0.0% | 3.2% | 2.6% | -0.0% | -0.0% | 0.2% | 0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-6.18 | $-3.86 | $-2.46 | $0.21 | $1.76 | $-0.51 | $-3.13 | $-1.86 | $-0.18 | $-1.15 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $41.9M | $53.1M | $65.0M | $69.7M | $71.4M | $75.4M | $77.6M | $94.2M | $114.6M | $120.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -181.73% |
| Rentabilidad sobre capital invertido | -135.38% |
| Rentabilidad sobre activos | -68.50% |
| Margen bruto | 63.55% |
| Margen operativo | -307.43% |
| Margen neto | -257.10% |
Salud financiera
| Deuda / Patrimonio | 0.62 |
| Ratio corriente | 1.77 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -9.26 | -1.96 | -2.81 | 13.96 | 9.39 | -4.19 | -2.11 | -1.32 | 5.52 | -0.98 |
| P/VC | 60.96 | 15.31 | -15.25 | 11.92 | 4.42 | 12.32 | -4.47 | -1.62 | -1.20 | 2.80 |
| P/V | 6.21 | 300.50 | 378.12 | 3.52 | 2.61 | 3.69 | 2.91 | 1.22 | 0.59 | 4.05 |
| Margen Bruto | -33.8% | -10216.9% | -107.9% | 95.2% | 92.1% | 82.4% | 66.8% | 38.2% | 56.0% | 57.9% |
| Margen Operativo | -61.0% | -14918.8% | -13137.3% | 30.3% | 32.9% | -80.8% | -121.7% | -79.0% | -41.8% | -425.7% |
| Margen Neto | -67.0% | -15306.6% | -13453.7% | 25.2% | 27.8% | -87.9% | -138.2% | -92.5% | 10.7% | -403.8% |